AG
OXFD

Aperio Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Aperio Group’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,065
Closed -$42K – 2942
2019
Q2 		$42K Buy
+3,065
New +$46.9K ﹤0.01% 2568

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Aperio Group's OXFD Position: Q3 2019 in Review

Aperio Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2019, closing a stake of 3,065 shares — an estimated $42K sold.

Aperio Group first reported a position in OXFD in Q2 2019 and held it in 1 quarter. The position peaked at $42K in Q2 2019. 73 funds tracked by Wall St. Rank hold OXFD as of Q3 2019.

  • Aperio Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2019 after selling out during the quarter.
  • Aperio Group sold 3,065 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2019, an estimated $42K.
  • Aperio Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2019 and held it in 1 quarter.
  • Aperio Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $42K in Q2 2019.
  • 73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.